In Cancer Care, Cost Matters

The New York Times
October 14, 2012

In this provocative New York Times op-ed, three MSK physicians, including Dr. Bach, announce their refusal to offer a cancer drug to patients because of its “phenomenally expensive” cost.

Read Full Article Here